
Network News

Merck announced that the European Commission granted approval for Ogsiveo for the treatment of adults with desmoid tumors. 18 Aug 2025 | Darmstadt, Germany Merck, a leading science and technology company, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase inhibitor, as monotherapy for the treatment of adults with progressing […]
read more
1.2 million euros in funding for the production of “gene taxis”
The Dietmar Hopp Foundation is supporting the establishment of an experimental production unit for gene therapies for the heart at Heidelberg University’s Medical Faculty, in the Department of Cardiology, Angiology, and Pneumology at Heidelberg University Hospital (UKHD). The new production capacities for therapeutic viruses, the “gene taxis” to the diseased heart, strengthen the pioneering role […]
read more
BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug Delivery
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists via BioMed X’s global talent sourcing and incubation model. Heidelberg, Germany, August 19th, 2025. BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new collaboration with Novo Nordisk, […]
read more
International Research Award in Dentistry goes to Heidelberg Institute of Global Health
A great honor for Professor Dr. Dr. Stefan Listl from the Medical Faculty of Heidelberg University: The International Association for Dental, Oral, and Craniofacial Research (IADR) honored him at its annual meeting with the prestigious Distinguished Scientist Award in the field of social science, epidemiology, and health services research. This award is one of the […]
read more
AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate
SEATTLE AND HEIDELBERG – July 29, 2025 – AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply drug substance for an investigational four-valent Shigella bioconjugate vaccine at the CDMO’s Heidelberg facility. Valneva exclusively licensed the vaccine candidate from LimmaTech Biologics AG, which […]
read more
From bench to code: collaboration unlocks insights into Alzheimer’s disease
How a chance encounter at a scientific conference resulted in a fruitful cross-Atlantic research collaboration In 2023, EMBL-EBI Postdoctoral Fellow Iguaracy Pinheiro de Sousa presented his bioinformatics work on how cells communicate within the heart, as part of the Network Biology meeting in Cold Spring Harbour, New York. “I met Yifei Cai during the opening […]
read more
NADHJA – Development of a miniaturized measurement system for non-invasive detection of the acute individual metabolic state using artificial intelligence
Lactate diagnostics is particularly important in sports medicine performance diagnostics and has been carried out conventionally for almost 100 years using blood samples and laboratory analyses. This project aims to develop a measurement method and functional model of a mobile device based on the NADHJA analyzer from mfd Diagnostics GmbH, which uses a fluorescence-optical method […]
read more
Launching BioLabs | TUM: Where science powers startups
Munich, Germany – BioLabs, TUM Venture Labs, and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in central Munich. The initiative aims to empower early-stage biotech startups by providing access to state-of-the-art lab infrastructure, expert mentoring, and global industry networks. Located in a refurbished 1,800-square-meter facility, BioLabs|TUM will offer fully […]
read more
New Research Unit in Basic Biomedical Research
German Research Foundation provides approx. five million euros in funding Heidelberg University has been successful in the most recent funding round of the German Research Foundation (DFG) with its proposal for a new DFG Research Unit in basic biomedical research. As part of this collaborative project, researchers are investigating the fundamental principles that enable organisms […]
read more